drugset / Trial / NCT01246518

Efficacy and Safety of Two Treatment Regimens of Topical MOB015 in Adults With Distal Subungual Onychomycosis

NCT01246518 ↗

Phase 2 Completed 250 enrolled Moberg Pharma AB
RandomizedParallel-groupOpen-labelTreatment

Summary

Onychomycosis is a fungal infection that affects fingernails and/or toenails. The purpose of this trial is to investigate if MOB015 is effective and safe for treatment of patients with fungal infection of the toenails.

Timeline

Start
2010-12
Primary completion
2012-10
Completion
2012-10

Drugs

EvaluationDrugModalityDoseRoute
Comparator MOB015 Unknown — Topical